BACKGROUND AND OBJECTIVES: Inaccurate determination of baseline kidney function can misclassify acute kidney injury (AKI) and affect the study of AKI-related outcomes. No consensus exists on how to optimally determine baseline kidney function when multiple preadmission creatinine measurements are available. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The accuracy of commonly used methods for estimating baseline serum creatinine was compared with that of a reference standard adjudicated by a panel of board-certified nephrologists in 379 patients with AKI or CKD admitted to a tertiary referral center. RESULTS: Agreement between estimating methods and the reference standard was highest when using creatinine values measured 7-365 days before admission. During this interval, the intraclass correlation coefficient (ICC) for the mean outpatient serum creatinine level (0.91 [95% confidence interval (CI), 0.88-0.92]) was higher than the most recent outpatient (ICC, 0.84 [95% CI, 0.80-0.88]; P<0.001) and the nadir outpatient (ICC, 0.83 [95% CI, 0.76-0.87; P<0.001) serum creatinine. Using the final creatinine value from a prior inpatient admission increased the ICC of the most recent outpatient creatinine method (0.88 [95% CI, 0.85-0.91]). Performance of all methods declined or was unchanged when the time interval was broadened to 2 years or included serum creatinine measured within a week of admission. CONCLUSIONS: The mean outpatient serum creatinine measured within a year of hospitalization most closely approximates nephrologist-adjudicated serum creatinine values.
BACKGROUND AND OBJECTIVES: Inaccurate determination of baseline kidney function can misclassify acute kidney injury (AKI) and affect the study of AKI-related outcomes. No consensus exists on how to optimally determine baseline kidney function when multiple preadmission creatinine measurements are available. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The accuracy of commonly used methods for estimating baseline serum creatinine was compared with that of a reference standard adjudicated by a panel of board-certified nephrologists in 379 patients with AKI or CKD admitted to a tertiary referral center. RESULTS: Agreement between estimating methods and the reference standard was highest when using creatinine values measured 7-365 days before admission. During this interval, the intraclass correlation coefficient (ICC) for the mean outpatient serum creatinine level (0.91 [95% confidence interval (CI), 0.88-0.92]) was higher than the most recent outpatient (ICC, 0.84 [95% CI, 0.80-0.88]; P<0.001) and the nadir outpatient (ICC, 0.83 [95% CI, 0.76-0.87; P<0.001) serum creatinine. Using the final creatinine value from a prior inpatient admission increased the ICC of the most recent outpatientcreatinine method (0.88 [95% CI, 0.85-0.91]). Performance of all methods declined or was unchanged when the time interval was broadened to 2 years or included serum creatinine measured within a week of admission. CONCLUSIONS: The mean outpatient serum creatinine measured within a year of hospitalization most closely approximates nephrologist-adjudicated serum creatinine values.
Authors: Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella Journal: Hypertension Date: 2004-12-20 Impact factor: 10.190
Authors: Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates Journal: J Am Soc Nephrol Date: 2005-09-21 Impact factor: 10.121
Authors: Benjamin J Powers; Maren K Olsen; Valerie A Smith; Robert F Woolson; Hayden B Bosworth; Eugene Z Oddone Journal: Ann Intern Med Date: 2011-06-21 Impact factor: 25.391
Authors: Josef Coresh; Brad C Astor; Geraldine McQuillan; John Kusek; Tom Greene; Frederick Van Lente; Andrew S Levey Journal: Am J Kidney Dis Date: 2002-05 Impact factor: 8.860
Authors: Eric A J Hoste; Gilles Clermont; Alexander Kersten; Ramesh Venkataraman; Derek C Angus; Dirk De Bacquer; John A Kellum Journal: Crit Care Date: 2006-05-12 Impact factor: 9.097
Authors: Xiaoxi Zeng; Gearoid M McMahon; Steven M Brunelli; David W Bates; Sushrut S Waikar Journal: Clin J Am Soc Nephrol Date: 2013-10-31 Impact factor: 8.237
Authors: Morgan E Grams; Sushrut S Waikar; Blaithin MacMahon; Seamus Whelton; Shoshana H Ballew; Josef Coresh Journal: Clin J Am Soc Nephrol Date: 2014-01-23 Impact factor: 8.237
Authors: Chi-yuan Hsu; Raymond K Hsu; Jingrong Yang; Juan D Ordonez; Sijie Zheng; Alan S Go Journal: J Am Soc Nephrol Date: 2015-07-01 Impact factor: 10.121
Authors: Dmytro Korenkevych; Tezcan Ozrazgat-Baslanti; Paul Thottakkara; Petar Momcilovic; Azra Bihorac; Charles E Hobson; Panos Pardalos Journal: Ann Surg Date: 2016-06 Impact factor: 12.969
Authors: Tezcan Ozrazgat-Baslanti; Paul Thottakkara; Matthew Huber; Kent Berg; Nikolaus Gravenstein; Patrick Tighe; Gloria Lipori; Mark S Segal; Charles Hobson; Azra Bihorac Journal: Ann Surg Date: 2016-12 Impact factor: 12.969
Authors: Molly Fisher; Joel Neugarten; Eran Bellin; Milagros Yunes; Lindsay Stahl; Tanya S Johns; Matthew K Abramowitz; Rebecca Levy; Neelja Kumar; Michele H Mokrzycki; Maria Coco; Mary Dominguez; Kalyan Prudhvi; Ladan Golestaneh Journal: J Am Soc Nephrol Date: 2020-07-15 Impact factor: 10.121
Authors: Zachary L Cox; Krishna Sury; Veena S Rao; Juan B Ivey-Miranda; Matthew Griffin; Devin Mahoney; Nicole Gomez; James H Fleming; Lesley A Inker; Steven G Coca; Jeff Turner; F Perry Wilson; Jeffrey M Testani Journal: J Card Fail Date: 2020-01-30 Impact factor: 5.712
Authors: Khaled Abdel-Kader; Timothy D Girard; Nathan E Brummel; Christina T Saunders; Jeffrey D Blume; Amanda J Clark; Andrew J Vincz; E Wesley Ely; James C Jackson; Susan P Bell; Kristin R Archer; T Alp Ikizler; Pratik P Pandharipande; Edward D Siew Journal: Crit Care Med Date: 2018-05 Impact factor: 7.598